Tag:
CareFusion
Latest Headlines
Latest Headlines
CareFusion sees Q3 profit dip in wake of Nicolet sale
CareFusion ($CFN) saw its profit dip to $31 million for its fiscal third quarter that ended March 31, down from $45 million a year earlier.
Natus bags CareFusion's neurodiagnostic business for $58M
California's CareFusion ($CFN) is streamlining. The medical device company is unloading its neurodiagnostic business, selling it to Natus Medical ($BABY) for $58 million.
B. Braun, CareFusion in patent disputes
B. Braun Medical has filed a patent infringement suit against CareFusion 303 involving the latter's Alaris system infusion pumps and smart medication systems. Five B. Braun patents are being asserted
CareFusion to sell ResMed ventilators in U.S.
When Kieran Gallahue quit as CEO of medical device company ResMed to go to another San Diego device company, CareFusion, 6 months ago, he apparently meant it when he said the parting was amicable.
CareFusion's COO to leave this summer
Wright Medical wasn't the only med device company to announce an executive departure Tuesday. Dwight Winstead, CareFusion's COO, will leave the company on June 30. "Dwight and I agreed the timing was
CareFusion sells ISP unit to Medline for $130M
Fresh on the heels of announcing its next CEO , CareFusion ( $CFN ) has agreed to sell its International Surgical Products (ISP) distribution business to Medline Industries for approximately $130
Kieran Gallahue to become new CareFusion CEO
San Diego-based CareFusion ( NYSE: CFN ) has tapped Kieran Gallahue as chairman and CEO. He will succeed David Schlotterbeck, who previously announced plans to retire later this month. Schlotterbeck
CareFusion plans 700 job cuts
Carefusion ( NYSE: CFN ), which boasts almost 15,000 employees in 20 countries, has announced that it's planning to cut 700 jobs, or 5 percent of its workforce. The cuts will hit management and support
Nautic completes Medegen sale to CareFusion
Private equity firm Nautic Partners has completed the previously announced sale of Ontario, CA-based Medegen to CareFusion for $225 million. Medegen develops, manufactures and markets disposable
Carefusion buys Medegen for $225M
CareFusion is buying Medegen, a maker of clinically differentiated needleless access valves and administration sets that deliver intravenous medication to patients, for $225 million in cash.
